摘要
目的 分析卵巢上皮癌淋巴结的转移情况 ,为患者选择淋巴结清除术提供科学依据。方法 采集 5 8例卵巢上皮癌患者的病历资料 ,并就患者腹膜后淋巴结转移的影响因素进行单因素和多因素分析。结果 5 8例卵巢上皮癌患者淋巴结转移率为 4 8.3% ,其中盆腔淋巴结转移率为37.9% ,腹主动脉旁淋巴结转移率为 2 5 .9% ,二者差异无显著性 (P >0 .0 5 )。单因素分析显示 ,肿瘤部位、腹水状况、临床分期和残留病灶直径与腹膜后淋巴结转移有关 ;多因素分析显示 ,临床分期和残留病灶直径为腹膜后淋巴结转移的独立危险因素。结论 对卵巢恶性肿瘤患者采用腹膜后淋巴结清除术极为重要 ,早期患者较为合适 ,而对曾有残留病灶的晚期患者 。
Objective To analyze the retroperitoneal lymph node metastasis in epithelial cancer of the ovary and offer scientific indications for lymph node radical dissection. Methods Fifty-eight patients with ovarian cancer treated from January 1990 to December 2000 were retrospectively reviewed. Single-factor and multifactor analysis with Logistic regression model were performed by SPSS 10.0 statistic software. Results The metastasis rates of overall lymph nodes, pelvic nodes and para-aortic nodes were 48.3%, 37.9% and 25.9% respectively, among which no significant difference was noted (P>0.05). Single-factor analysis showed that tumor location, ascitic condition, clinical stage and the size of residual tumor were associated with retroperitoneal lymph node metastasis. Multifactor analysis revealed that clinical stage and size of residual tumor were independent risk factors for metastasis of retroperitoneal lymph nodes. Conclusion For early ovarian cancer patients, it is extremely important to perform radical dissection of the retroperitoneal lymph nodes. For advanced or residual lesions, radical dissection of pelvic nodes and para-aortic nodes could be considered in the second exploration.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2004年第8期499-501,共3页
Chinese Journal of Oncology
关键词
卵巢上皮癌
腹膜
淋巴结转移
卵巢肿瘤
化疗
Ovarian neoplasms/therapy
Epithelial cancer/ therapy
Lymphatic metastasis
Prognosis